Blog
Therapies for Resistant & Recurrent Metastatic Cancer Market Expected to Witness Strong Uptake by 2032
The global market for therapies targeting resistant and recurrent metastatic cancer is gaining increased attention, driven by high unmet medical needs in oncology. Emerging research
Allied Market Research
November 3, 2025